Sign in

CIK 0001035354

  • Non-accelerated filer
  • Smaller reporting company

Eloxx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELOX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841368850
Phone
+1 781-577-5300
Business address
P.O. BOX 274, ARLINGTON, MA, 02476
Former names
Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2011-09-30 Isabelle Warren John Director Grant or award · Common Stock Option +155,000 280,000
2011-09-30 STALDER RUEDI Director Grant or award · Common Stock +155,000 1,316,787
2011-09-30 THOMPSON JOHN PHD EVP and CSO Grant or award · Common Stock Option +468,000 1,263,676
2011-09-30 Van Hulst Jack Director Grant or award · Common Stock Option +155,000 835,375
2011-09-30 Browne Leslie J President and CEO Grant or award · Common Stock Option +819,000 $2,544,000.00 $2083.5B 0
2011-09-30 BROOKS JOEL CFO, Secretary and Treasurer Grant or award · Common Stock Option +468,000 1,325,500
2011-09-30 Dondero Richard S VP - Research and Development Grant or award · Common Stock Option +468,000 1,460,924
2011-09-30 QUICK THOMAS C Director Grant or award · Common Stock Option +155,000 755,373
2011-09-30 RECTOR DAVID Director Grant or award · Common Stock Option +230,000 921,797
2011-09-30 Waksal Harlan Director Grant or award · Common Stock Option +305,000 1,462,654
2011-06-13 RECTOR DAVID Director Purchase +20,000 $0.27 $5K 270,746

Page 26 of 26 · 511 trades